Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
185.40
+3.39 (1.86%)
At close: Mar 9, 2026, 4:00 PM EDT
185.41
+0.01 (0.01%)
After-hours: Mar 9, 2026, 7:51 PM EDT
Jazz Pharmaceuticals Revenue by Segment
History
| Date | Neuroscience | Oncology |
|---|---|---|
| Dec 31, 2025 | 2.88B | 1.13B |
| Sep 30, 2025 | 2.82B | 1.08B |
| Jun 30, 2025 | 2.75B | 1.08B |
| Mar 31, 2025 | 2.72B | 1.08B |
| Dec 31, 2024 | 2.70B | 1.11B |
| Sep 30, 2024 | 2.66B | 1.09B |
| Jun 30, 2024 | 2.63B | 1.07B |
| Mar 31, 2024 | 2.64B | 1.04B |
| Dec 31, 2023 | 2.71B | 1.02B |
| Sep 30, 2023 | 2.76B | 965.36M |
| Jun 30, 2023 | 2.80B | 928.30M |
| Mar 31, 2023 | 2.80B | 905.92M |
| Dec 31, 2022 | 2.76B | 873.84M |
| Sep 30, 2022 | 2.71B | 857.05M |
| Jun 30, 2022 | 2.64B | 818.48M |
| Mar 31, 2022 | 2.52B | 752.44M |
| Dec 31, 2021 | 2.34B | 733.81M |
| Sep 30, 2021 | 2.11B | 723.21M |
| Jun 30, 2021 | 1.92B | 676.58M |
| Mar 31, 2021 | 1.80B | 650.94M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.